Global Clinical Trial Material Production, Demand and Key Producers, 2022-2028
Clinical Trial Material means any raw materials, parts, or supplies used in the ordinary course of development of a Product for which regulatory approval has not yet been obtained and that are used exclusively for purposes of supporting clinical and preclinical research.
This report studies the global Clinical Trial Material demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Clinical Trial Material, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Clinical Trial Material that contribute to its increasing demand across many markets.
The global Clinical Trial Material market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Clinical Trial Material total market, 2017-2028, (USD Million)
Global Clinical Trial Material total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Clinical Trial Material total market, key domestic companies and share, (USD Million)
Global Clinical Trial Material revenue by player and market share 2017-2022, (USD Million)
Global Clinical Trial Material total market by Type, CAGR, 2017-2028, (USD Million)
Global Clinical Trial Material total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Clinical Trial Material market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Marken, Catalent, Eurofins Scientific, Biocair, Almac Group, Piramal Pharma Solutions, Parexel and PRA Health Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Clinical Trial Material market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Clinical Trial Material Market, By Region:
1. How big is the global Clinical Trial Material market?
2. What is the demand of the global Clinical Trial Material market?
3. What is the year over year growth of the global Clinical Trial Material market?
4. What is the total value of the global Clinical Trial Material market?
5. Who are the major players in the global Clinical Trial Material market?
6. What are the growth factors driving the market demand?
This report studies the global Clinical Trial Material demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Clinical Trial Material, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Clinical Trial Material that contribute to its increasing demand across many markets.
The global Clinical Trial Material market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Clinical Trial Material total market, 2017-2028, (USD Million)
Global Clinical Trial Material total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Clinical Trial Material total market, key domestic companies and share, (USD Million)
Global Clinical Trial Material revenue by player and market share 2017-2022, (USD Million)
Global Clinical Trial Material total market by Type, CAGR, 2017-2028, (USD Million)
Global Clinical Trial Material total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Clinical Trial Material market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Marken, Catalent, Eurofins Scientific, Biocair, Almac Group, Piramal Pharma Solutions, Parexel and PRA Health Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Clinical Trial Material market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Clinical Trial Material Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Small-molecules
- Biologic Drugs
- Medical Devices
- Oncology
- CNS
- Cardiovascular Diseases
- Digestive Disorders
- Immunology
- Blood Disorders
- Other
- Thermo Fisher Scientific
- Marken
- Catalent
- Eurofins Scientific
- Biocair
- Almac Group
- Piramal Pharma Solutions
- Parexel
- PRA Health Sciences
- PCI Pharma Services
- Capsugel
- OCT Group
- Acnos Pharma
- KLIFO
- Ancillare, LP
- ADAllen Pharma
- Recipharm
- Movianto
1. How big is the global Clinical Trial Material market?
2. What is the demand of the global Clinical Trial Material market?
3. What is the year over year growth of the global Clinical Trial Material market?
4. What is the total value of the global Clinical Trial Material market?
5. Who are the major players in the global Clinical Trial Material market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Clinical Trial Material Introduction
1.2 World Clinical Trial Material Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Clinical Trial Material Total Market by Region
1.3.1 World Clinical Trial Material Market Size by Region (2017-2028)
1.3.2 United States Clinical Trial Material Market Size (2017-2028)
1.3.3 China Clinical Trial Material Market Size (2017-2028)
1.3.4 Europe Clinical Trial Material Market Size (2017-2028)
1.3.5 Japan Clinical Trial Material Market Size (2017-2028)
1.3.6 South Korea Clinical Trial Material Market Size (2017-2028)
1.3.7 ASEAN Clinical Trial Material Market Size (2017-2028)
1.3.8 India Clinical Trial Material Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Clinical Trial Material Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Clinical Trial Material Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CLINICAL TRIAL MATERIAL COMPANIES COMPETITIVE ANALYSIS
2.1 World Clinical Trial Material Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Clinical Trial Material Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Clinical Trial Material in 2021
2.2.3 Global Concentration Ratios (CR8) for Clinical Trial Material in 2021
2.3 Clinical Trial Material Company Evaluation Quadrant
2.4 Clinical Trial Material Market: Overall Company Footprint Analysis
2.4.1 Clinical Trial Material Market: Region Footprint
2.4.2 Clinical Trial Material Market: Company Product Type Footprint
2.4.3 Clinical Trial Material Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Clinical Trial Material Market Comparison
3.1.1 United States VS China: Clinical Trial Material Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Clinical Trial Material Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Clinical Trial Material Major Players and Market Share, 2017-2022
3.2.1 Major Players of Clinical Trial Material in United States, Headquarters (States, Country)
3.2.2 United States Clinical Trial Material Revenue by Domestic Player, (2017-2022)
3.3 China Clinical Trial Material Major Players and Market Share, 2017-2022
3.3.1 Major Players of Clinical Trial Material in China, Headquarters (Province, Country)
3.3.2 China Clinical Trial Material Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Clinical Trial Material Major Players and Market Share, 2017-2022
3.4.1 Major Players of Clinical Trial Material in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Clinical Trial Material Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Clinical Trial Material Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Small-molecules
4.2.2 Biologic Drugs
4.2.3 Medical Devices
4.3 Market Segment by Type
4.3.1 World Clinical Trial Material Market Size by Type (2017-2022)
4.3.2 World Clinical Trial Material Market Size by Type (2023-2028)
4.3.3 World Clinical Trial Material Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Clinical Trial Material Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Oncology
5.2.2 CNS
5.2.3 Cardiovascular Diseases
5.2.4 Digestive Disorders
5.2.5 Digestive Disorders
5.2.6 Blood Disorders
5.2.7 Other
5.3 Market Segment by Application
5.3.1 World Clinical Trial Material Market Size by Application (2017-2022)
5.3.2 World Clinical Trial Material Market Size by Application (2023-2028)
5.3.3 World Clinical Trial Material Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Details
6.1.2 Thermo Fisher Scientific Major Business
6.1.3 Thermo Fisher Scientific Clinical Trial Material Product and Services
6.1.4 Thermo Fisher Scientific Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
6.2 Marken
6.2.1 Marken Details
6.2.2 Marken Major Business
6.2.3 Marken Clinical Trial Material Product and Services
6.2.4 Marken Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Marken Recent Developments/Updates
6.2.6 Marken Competitive Strengths & Weaknesses
6.3 Catalent
6.3.1 Catalent Details
6.3.2 Catalent Major Business
6.3.3 Catalent Clinical Trial Material Product and Services
6.3.4 Catalent Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Catalent Recent Developments/Updates
6.3.6 Catalent Competitive Strengths & Weaknesses
6.4 Eurofins Scientific
6.4.1 Eurofins Scientific Details
6.4.2 Eurofins Scientific Major Business
6.4.3 Eurofins Scientific Clinical Trial Material Product and Services
6.4.4 Eurofins Scientific Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Eurofins Scientific Recent Developments/Updates
6.4.6 Eurofins Scientific Competitive Strengths & Weaknesses
6.5 Biocair
6.5.1 Biocair Details
6.5.2 Biocair Major Business
6.5.3 Biocair Clinical Trial Material Product and Services
6.5.4 Biocair Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Biocair Recent Developments/Updates
6.5.6 Biocair Competitive Strengths & Weaknesses
6.6 Almac Group
6.6.1 Almac Group Details
6.6.2 Almac Group Major Business
6.6.3 Almac Group Clinical Trial Material Product and Services
6.6.4 Almac Group Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Almac Group Recent Developments/Updates
6.6.6 Almac Group Competitive Strengths & Weaknesses
6.7 Piramal Pharma Solutions
6.7.1 Piramal Pharma Solutions Details
6.7.2 Piramal Pharma Solutions Major Business
6.7.3 Piramal Pharma Solutions Clinical Trial Material Product and Services
6.7.4 Piramal Pharma Solutions Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Piramal Pharma Solutions Recent Developments/Updates
6.7.6 Piramal Pharma Solutions Competitive Strengths & Weaknesses
6.8 Parexel
6.8.1 Parexel Details
6.8.2 Parexel Major Business
6.8.3 Parexel Clinical Trial Material Product and Services
6.8.4 Parexel Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Parexel Recent Developments/Updates
6.8.6 Parexel Competitive Strengths & Weaknesses
6.9 PRA Health Sciences
6.9.1 PRA Health Sciences Details
6.9.2 PRA Health Sciences Major Business
6.9.3 PRA Health Sciences Clinical Trial Material Product and Services
6.9.4 PRA Health Sciences Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 PRA Health Sciences Recent Developments/Updates
6.9.6 PRA Health Sciences Competitive Strengths & Weaknesses
6.10 PCI Pharma Services
6.10.1 PCI Pharma Services Details
6.10.2 PCI Pharma Services Major Business
6.10.3 PCI Pharma Services Clinical Trial Material Product and Services
6.10.4 PCI Pharma Services Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 PCI Pharma Services Recent Developments/Updates
6.10.6 PCI Pharma Services Competitive Strengths & Weaknesses
6.11 Capsugel
6.11.1 Capsugel Details
6.11.2 Capsugel Major Business
6.11.3 Capsugel Clinical Trial Material Product and Services
6.11.4 Capsugel Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Capsugel Recent Developments/Updates
6.11.6 Capsugel Competitive Strengths & Weaknesses
6.12 OCT Group
6.12.1 OCT Group Details
6.12.2 OCT Group Major Business
6.12.3 OCT Group Clinical Trial Material Product and Services
6.12.4 OCT Group Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 OCT Group Recent Developments/Updates
6.12.6 OCT Group Competitive Strengths & Weaknesses
6.13 Acnos Pharma
6.13.1 Acnos Pharma Details
6.13.2 Acnos Pharma Major Business
6.13.3 Acnos Pharma Clinical Trial Material Product and Services
6.13.4 Acnos Pharma Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Acnos Pharma Recent Developments/Updates
6.13.6 Acnos Pharma Competitive Strengths & Weaknesses
6.14 KLIFO
6.14.1 KLIFO Details
6.14.2 KLIFO Major Business
6.14.3 KLIFO Clinical Trial Material Product and Services
6.14.4 KLIFO Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 KLIFO Recent Developments/Updates
6.14.6 KLIFO Competitive Strengths & Weaknesses
6.15 Ancillare, LP
6.15.1 Ancillare, LP Details
6.15.2 Ancillare, LP Major Business
6.15.3 Ancillare, LP Clinical Trial Material Product and Services
6.15.4 Ancillare, LP Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Ancillare, LP Recent Developments/Updates
6.15.6 Ancillare, LP Competitive Strengths & Weaknesses
6.16 ADAllen Pharma
6.16.1 ADAllen Pharma Details
6.16.2 ADAllen Pharma Major Business
6.16.3 ADAllen Pharma Clinical Trial Material Product and Services
6.16.4 ADAllen Pharma Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 ADAllen Pharma Recent Developments/Updates
6.16.6 ADAllen Pharma Competitive Strengths & Weaknesses
6.17 Recipharm
6.17.1 Recipharm Details
6.17.2 Recipharm Major Business
6.17.3 Recipharm Clinical Trial Material Product and Services
6.17.4 Recipharm Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Recipharm Recent Developments/Updates
6.17.6 Recipharm Competitive Strengths & Weaknesses
6.18 Movianto
6.18.1 Movianto Details
6.18.2 Movianto Major Business
6.18.3 Movianto Clinical Trial Material Product and Services
6.18.4 Movianto Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Movianto Recent Developments/Updates
6.18.6 Movianto Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Clinical Trial Material and Key Manufacturers
7.2 Clinical Trial Material Manufacturing Costs
7.3 Clinical Trial Material Production Process
7.4 Clinical Trial Material Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Clinical Trial Material Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Clinical Trial Material Typical Distributors
8.3 Clinical Trial Material Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Clinical Trial Material Introduction
1.2 World Clinical Trial Material Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Clinical Trial Material Total Market by Region
1.3.1 World Clinical Trial Material Market Size by Region (2017-2028)
1.3.2 United States Clinical Trial Material Market Size (2017-2028)
1.3.3 China Clinical Trial Material Market Size (2017-2028)
1.3.4 Europe Clinical Trial Material Market Size (2017-2028)
1.3.5 Japan Clinical Trial Material Market Size (2017-2028)
1.3.6 South Korea Clinical Trial Material Market Size (2017-2028)
1.3.7 ASEAN Clinical Trial Material Market Size (2017-2028)
1.3.8 India Clinical Trial Material Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Clinical Trial Material Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Clinical Trial Material Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CLINICAL TRIAL MATERIAL COMPANIES COMPETITIVE ANALYSIS
2.1 World Clinical Trial Material Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Clinical Trial Material Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Clinical Trial Material in 2021
2.2.3 Global Concentration Ratios (CR8) for Clinical Trial Material in 2021
2.3 Clinical Trial Material Company Evaluation Quadrant
2.4 Clinical Trial Material Market: Overall Company Footprint Analysis
2.4.1 Clinical Trial Material Market: Region Footprint
2.4.2 Clinical Trial Material Market: Company Product Type Footprint
2.4.3 Clinical Trial Material Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Clinical Trial Material Market Comparison
3.1.1 United States VS China: Clinical Trial Material Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Clinical Trial Material Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Clinical Trial Material Major Players and Market Share, 2017-2022
3.2.1 Major Players of Clinical Trial Material in United States, Headquarters (States, Country)
3.2.2 United States Clinical Trial Material Revenue by Domestic Player, (2017-2022)
3.3 China Clinical Trial Material Major Players and Market Share, 2017-2022
3.3.1 Major Players of Clinical Trial Material in China, Headquarters (Province, Country)
3.3.2 China Clinical Trial Material Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Clinical Trial Material Major Players and Market Share, 2017-2022
3.4.1 Major Players of Clinical Trial Material in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Clinical Trial Material Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Clinical Trial Material Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Small-molecules
4.2.2 Biologic Drugs
4.2.3 Medical Devices
4.3 Market Segment by Type
4.3.1 World Clinical Trial Material Market Size by Type (2017-2022)
4.3.2 World Clinical Trial Material Market Size by Type (2023-2028)
4.3.3 World Clinical Trial Material Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Clinical Trial Material Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Oncology
5.2.2 CNS
5.2.3 Cardiovascular Diseases
5.2.4 Digestive Disorders
5.2.5 Digestive Disorders
5.2.6 Blood Disorders
5.2.7 Other
5.3 Market Segment by Application
5.3.1 World Clinical Trial Material Market Size by Application (2017-2022)
5.3.2 World Clinical Trial Material Market Size by Application (2023-2028)
5.3.3 World Clinical Trial Material Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Details
6.1.2 Thermo Fisher Scientific Major Business
6.1.3 Thermo Fisher Scientific Clinical Trial Material Product and Services
6.1.4 Thermo Fisher Scientific Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
6.2 Marken
6.2.1 Marken Details
6.2.2 Marken Major Business
6.2.3 Marken Clinical Trial Material Product and Services
6.2.4 Marken Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Marken Recent Developments/Updates
6.2.6 Marken Competitive Strengths & Weaknesses
6.3 Catalent
6.3.1 Catalent Details
6.3.2 Catalent Major Business
6.3.3 Catalent Clinical Trial Material Product and Services
6.3.4 Catalent Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Catalent Recent Developments/Updates
6.3.6 Catalent Competitive Strengths & Weaknesses
6.4 Eurofins Scientific
6.4.1 Eurofins Scientific Details
6.4.2 Eurofins Scientific Major Business
6.4.3 Eurofins Scientific Clinical Trial Material Product and Services
6.4.4 Eurofins Scientific Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Eurofins Scientific Recent Developments/Updates
6.4.6 Eurofins Scientific Competitive Strengths & Weaknesses
6.5 Biocair
6.5.1 Biocair Details
6.5.2 Biocair Major Business
6.5.3 Biocair Clinical Trial Material Product and Services
6.5.4 Biocair Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Biocair Recent Developments/Updates
6.5.6 Biocair Competitive Strengths & Weaknesses
6.6 Almac Group
6.6.1 Almac Group Details
6.6.2 Almac Group Major Business
6.6.3 Almac Group Clinical Trial Material Product and Services
6.6.4 Almac Group Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Almac Group Recent Developments/Updates
6.6.6 Almac Group Competitive Strengths & Weaknesses
6.7 Piramal Pharma Solutions
6.7.1 Piramal Pharma Solutions Details
6.7.2 Piramal Pharma Solutions Major Business
6.7.3 Piramal Pharma Solutions Clinical Trial Material Product and Services
6.7.4 Piramal Pharma Solutions Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Piramal Pharma Solutions Recent Developments/Updates
6.7.6 Piramal Pharma Solutions Competitive Strengths & Weaknesses
6.8 Parexel
6.8.1 Parexel Details
6.8.2 Parexel Major Business
6.8.3 Parexel Clinical Trial Material Product and Services
6.8.4 Parexel Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Parexel Recent Developments/Updates
6.8.6 Parexel Competitive Strengths & Weaknesses
6.9 PRA Health Sciences
6.9.1 PRA Health Sciences Details
6.9.2 PRA Health Sciences Major Business
6.9.3 PRA Health Sciences Clinical Trial Material Product and Services
6.9.4 PRA Health Sciences Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 PRA Health Sciences Recent Developments/Updates
6.9.6 PRA Health Sciences Competitive Strengths & Weaknesses
6.10 PCI Pharma Services
6.10.1 PCI Pharma Services Details
6.10.2 PCI Pharma Services Major Business
6.10.3 PCI Pharma Services Clinical Trial Material Product and Services
6.10.4 PCI Pharma Services Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 PCI Pharma Services Recent Developments/Updates
6.10.6 PCI Pharma Services Competitive Strengths & Weaknesses
6.11 Capsugel
6.11.1 Capsugel Details
6.11.2 Capsugel Major Business
6.11.3 Capsugel Clinical Trial Material Product and Services
6.11.4 Capsugel Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Capsugel Recent Developments/Updates
6.11.6 Capsugel Competitive Strengths & Weaknesses
6.12 OCT Group
6.12.1 OCT Group Details
6.12.2 OCT Group Major Business
6.12.3 OCT Group Clinical Trial Material Product and Services
6.12.4 OCT Group Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 OCT Group Recent Developments/Updates
6.12.6 OCT Group Competitive Strengths & Weaknesses
6.13 Acnos Pharma
6.13.1 Acnos Pharma Details
6.13.2 Acnos Pharma Major Business
6.13.3 Acnos Pharma Clinical Trial Material Product and Services
6.13.4 Acnos Pharma Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Acnos Pharma Recent Developments/Updates
6.13.6 Acnos Pharma Competitive Strengths & Weaknesses
6.14 KLIFO
6.14.1 KLIFO Details
6.14.2 KLIFO Major Business
6.14.3 KLIFO Clinical Trial Material Product and Services
6.14.4 KLIFO Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 KLIFO Recent Developments/Updates
6.14.6 KLIFO Competitive Strengths & Weaknesses
6.15 Ancillare, LP
6.15.1 Ancillare, LP Details
6.15.2 Ancillare, LP Major Business
6.15.3 Ancillare, LP Clinical Trial Material Product and Services
6.15.4 Ancillare, LP Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Ancillare, LP Recent Developments/Updates
6.15.6 Ancillare, LP Competitive Strengths & Weaknesses
6.16 ADAllen Pharma
6.16.1 ADAllen Pharma Details
6.16.2 ADAllen Pharma Major Business
6.16.3 ADAllen Pharma Clinical Trial Material Product and Services
6.16.4 ADAllen Pharma Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 ADAllen Pharma Recent Developments/Updates
6.16.6 ADAllen Pharma Competitive Strengths & Weaknesses
6.17 Recipharm
6.17.1 Recipharm Details
6.17.2 Recipharm Major Business
6.17.3 Recipharm Clinical Trial Material Product and Services
6.17.4 Recipharm Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Recipharm Recent Developments/Updates
6.17.6 Recipharm Competitive Strengths & Weaknesses
6.18 Movianto
6.18.1 Movianto Details
6.18.2 Movianto Major Business
6.18.3 Movianto Clinical Trial Material Product and Services
6.18.4 Movianto Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Movianto Recent Developments/Updates
6.18.6 Movianto Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Clinical Trial Material and Key Manufacturers
7.2 Clinical Trial Material Manufacturing Costs
7.3 Clinical Trial Material Production Process
7.4 Clinical Trial Material Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Clinical Trial Material Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Clinical Trial Material Typical Distributors
8.3 Clinical Trial Material Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Clinical Trial Material Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Clinical Trial Material Market Size by Region (2017-2022) & (USD Million)
Table 3. World Clinical Trial Material Market Size by Region (2023-2028) & (USD Million)
Table 4. World Clinical Trial Material Market Size Market Share by Region (2017-2022)
Table 5. World Clinical Trial Material Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Clinical Trial Material Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Clinical Trial Material Players in 2021
Table 9. World Clinical Trial Material Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Clinical Trial Material Company Evaluation Quadrant
Table 11. Head Office of Key Clinical Trial Material Player
Table 12. Clinical Trial Material Market: Company Product Type Footprint
Table 13. Clinical Trial Material Market: Company Product Application Footprint
Table 14. Clinical Trial Material Mergers & Acquisitions Activity
Table 15. United States VS China Clinical Trial Material Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Clinical Trial Material in United States, Headquarters (States, Country)
Table 17. United States Clinical Trial Material Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Clinical Trial Material Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Clinical Trial Material in China, Company Headquarters (Province, Country)
Table 20. China Clinical Trial Material Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Clinical Trial Material Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Clinical Trial Material in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Clinical Trial Material Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Clinical Trial Material Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Clinical Trial Material Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Clinical Trial Material Revenue by Type (2017-2022) & (USD Million)
Table 27. World Clinical Trial Material Revenue by Type (2023-2028) & (USD Million)
Table 28. World Clinical Trial Material Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Clinical Trial Material Revenue by Application (2017-2022) & (USD Million)
Table 30. World Clinical Trial Material Revenue by Application (2023-2028) & (USD Million)
Table 31. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 32. Thermo Fisher Scientific Major Business
Table 33. Thermo Fisher Scientific Clinical Trial Material Product and Services
Table 34. Thermo Fisher Scientific Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Thermo Fisher Scientific Recent Developments/Updates
Table 36. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 37. Marken Basic Information, Area Served and Competitors
Table 38. Marken Major Business
Table 39. Marken Clinical Trial Material Product and Services
Table 40. Marken Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Marken Recent Developments/Updates
Table 42. Marken Competitive Strengths & Weaknesses
Table 43. Catalent Basic Information, Area Served and Competitors
Table 44. Catalent Major Business
Table 45. Catalent Clinical Trial Material Product and Services
Table 46. Catalent Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Catalent Recent Developments/Updates
Table 48. Catalent Competitive Strengths & Weaknesses
Table 49. Eurofins Scientific Basic Information, Area Served and Competitors
Table 50. Eurofins Scientific Major Business
Table 51. Eurofins Scientific Clinical Trial Material Product and Services
Table 52. Eurofins Scientific Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Eurofins Scientific Recent Developments/Updates
Table 54. Eurofins Scientific Competitive Strengths & Weaknesses
Table 55. Biocair Basic Information, Area Served and Competitors
Table 56. Biocair Major Business
Table 57. Biocair Clinical Trial Material Product and Services
Table 58. Biocair Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Biocair Recent Developments/Updates
Table 60. Biocair Competitive Strengths & Weaknesses
Table 61. Almac Group Basic Information, Area Served and Competitors
Table 62. Almac Group Major Business
Table 63. Almac Group Clinical Trial Material Product and Services
Table 64. Almac Group Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Almac Group Recent Developments/Updates
Table 66. Almac Group Competitive Strengths & Weaknesses
Table 67. Piramal Pharma Solutions Basic Information, Area Served and Competitors
Table 68. Piramal Pharma Solutions Major Business
Table 69. Piramal Pharma Solutions Clinical Trial Material Product and Services
Table 70. Piramal Pharma Solutions Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Piramal Pharma Solutions Recent Developments/Updates
Table 72. Piramal Pharma Solutions Competitive Strengths & Weaknesses
Table 73. Parexel Basic Information, Area Served and Competitors
Table 74. Parexel Major Business
Table 75. Parexel Clinical Trial Material Product and Services
Table 76. Parexel Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Parexel Recent Developments/Updates
Table 78. Parexel Competitive Strengths & Weaknesses
Table 79. PRA Health Sciences Basic Information, Area Served and Competitors
Table 80. PRA Health Sciences Major Business
Table 81. PRA Health Sciences Clinical Trial Material Product and Services
Table 82. PRA Health Sciences Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. PRA Health Sciences Recent Developments/Updates
Table 84. PRA Health Sciences Competitive Strengths & Weaknesses
Table 85. PCI Pharma Services Basic Information, Area Served and Competitors
Table 86. PCI Pharma Services Major Business
Table 87. PCI Pharma Services Clinical Trial Material Product and Services
Table 88. PCI Pharma Services Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. PCI Pharma Services Recent Developments/Updates
Table 90. PCI Pharma Services Competitive Strengths & Weaknesses
Table 91. Capsugel Basic Information, Area Served and Competitors
Table 92. Capsugel Major Business
Table 93. Capsugel Clinical Trial Material Product and Services
Table 94. Capsugel Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Capsugel Recent Developments/Updates
Table 96. Capsugel Competitive Strengths & Weaknesses
Table 97. OCT Group Basic Information, Area Served and Competitors
Table 98. OCT Group Major Business
Table 99. OCT Group Clinical Trial Material Product and Services
Table 100. OCT Group Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. OCT Group Recent Developments/Updates
Table 102. OCT Group Competitive Strengths & Weaknesses
Table 103. Acnos Pharma Basic Information, Area Served and Competitors
Table 104. Acnos Pharma Major Business
Table 105. Acnos Pharma Clinical Trial Material Product and Services
Table 106. Acnos Pharma Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Acnos Pharma Recent Developments/Updates
Table 108. Acnos Pharma Competitive Strengths & Weaknesses
Table 109. KLIFO Basic Information, Area Served and Competitors
Table 110. KLIFO Major Business
Table 111. KLIFO Clinical Trial Material Product and Services
Table 112. KLIFO Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. KLIFO Recent Developments/Updates
Table 114. KLIFO Competitive Strengths & Weaknesses
Table 115. Ancillare, LP Basic Information, Area Served and Competitors
Table 116. Ancillare, LP Major Business
Table 117. Ancillare, LP Clinical Trial Material Product and Services
Table 118. Ancillare, LP Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Ancillare, LP Recent Developments/Updates
Table 120. Ancillare, LP Competitive Strengths & Weaknesses
Table 121. ADAllen Pharma Basic Information, Area Served and Competitors
Table 122. ADAllen Pharma Major Business
Table 123. ADAllen Pharma Clinical Trial Material Product and Services
Table 124. ADAllen Pharma Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. ADAllen Pharma Recent Developments/Updates
Table 126. ADAllen Pharma Competitive Strengths & Weaknesses
Table 127. Recipharm Basic Information, Area Served and Competitors
Table 128. Recipharm Major Business
Table 129. Recipharm Clinical Trial Material Product and Services
Table 130. Recipharm Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Recipharm Recent Developments/Updates
Table 132. Movianto Basic Information, Area Served and Competitors
Table 133. Movianto Major Business
Table 134. Movianto Clinical Trial Material Product and Services
Table 135. Movianto Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 136. Clinical Trial Material Raw Material
Table 137. Key Manufacturers of Clinical Trial Material Raw Materials
Table 138. Clinical Trial Material Typical Distributors
Table 139. Clinical Trial Material Typical Customers
Table 1. World Clinical Trial Material Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Clinical Trial Material Market Size by Region (2017-2022) & (USD Million)
Table 3. World Clinical Trial Material Market Size by Region (2023-2028) & (USD Million)
Table 4. World Clinical Trial Material Market Size Market Share by Region (2017-2022)
Table 5. World Clinical Trial Material Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Clinical Trial Material Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Clinical Trial Material Players in 2021
Table 9. World Clinical Trial Material Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Clinical Trial Material Company Evaluation Quadrant
Table 11. Head Office of Key Clinical Trial Material Player
Table 12. Clinical Trial Material Market: Company Product Type Footprint
Table 13. Clinical Trial Material Market: Company Product Application Footprint
Table 14. Clinical Trial Material Mergers & Acquisitions Activity
Table 15. United States VS China Clinical Trial Material Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Clinical Trial Material in United States, Headquarters (States, Country)
Table 17. United States Clinical Trial Material Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Clinical Trial Material Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Clinical Trial Material in China, Company Headquarters (Province, Country)
Table 20. China Clinical Trial Material Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Clinical Trial Material Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Clinical Trial Material in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Clinical Trial Material Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Clinical Trial Material Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Clinical Trial Material Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Clinical Trial Material Revenue by Type (2017-2022) & (USD Million)
Table 27. World Clinical Trial Material Revenue by Type (2023-2028) & (USD Million)
Table 28. World Clinical Trial Material Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Clinical Trial Material Revenue by Application (2017-2022) & (USD Million)
Table 30. World Clinical Trial Material Revenue by Application (2023-2028) & (USD Million)
Table 31. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 32. Thermo Fisher Scientific Major Business
Table 33. Thermo Fisher Scientific Clinical Trial Material Product and Services
Table 34. Thermo Fisher Scientific Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Thermo Fisher Scientific Recent Developments/Updates
Table 36. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 37. Marken Basic Information, Area Served and Competitors
Table 38. Marken Major Business
Table 39. Marken Clinical Trial Material Product and Services
Table 40. Marken Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Marken Recent Developments/Updates
Table 42. Marken Competitive Strengths & Weaknesses
Table 43. Catalent Basic Information, Area Served and Competitors
Table 44. Catalent Major Business
Table 45. Catalent Clinical Trial Material Product and Services
Table 46. Catalent Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Catalent Recent Developments/Updates
Table 48. Catalent Competitive Strengths & Weaknesses
Table 49. Eurofins Scientific Basic Information, Area Served and Competitors
Table 50. Eurofins Scientific Major Business
Table 51. Eurofins Scientific Clinical Trial Material Product and Services
Table 52. Eurofins Scientific Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Eurofins Scientific Recent Developments/Updates
Table 54. Eurofins Scientific Competitive Strengths & Weaknesses
Table 55. Biocair Basic Information, Area Served and Competitors
Table 56. Biocair Major Business
Table 57. Biocair Clinical Trial Material Product and Services
Table 58. Biocair Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Biocair Recent Developments/Updates
Table 60. Biocair Competitive Strengths & Weaknesses
Table 61. Almac Group Basic Information, Area Served and Competitors
Table 62. Almac Group Major Business
Table 63. Almac Group Clinical Trial Material Product and Services
Table 64. Almac Group Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Almac Group Recent Developments/Updates
Table 66. Almac Group Competitive Strengths & Weaknesses
Table 67. Piramal Pharma Solutions Basic Information, Area Served and Competitors
Table 68. Piramal Pharma Solutions Major Business
Table 69. Piramal Pharma Solutions Clinical Trial Material Product and Services
Table 70. Piramal Pharma Solutions Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Piramal Pharma Solutions Recent Developments/Updates
Table 72. Piramal Pharma Solutions Competitive Strengths & Weaknesses
Table 73. Parexel Basic Information, Area Served and Competitors
Table 74. Parexel Major Business
Table 75. Parexel Clinical Trial Material Product and Services
Table 76. Parexel Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Parexel Recent Developments/Updates
Table 78. Parexel Competitive Strengths & Weaknesses
Table 79. PRA Health Sciences Basic Information, Area Served and Competitors
Table 80. PRA Health Sciences Major Business
Table 81. PRA Health Sciences Clinical Trial Material Product and Services
Table 82. PRA Health Sciences Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. PRA Health Sciences Recent Developments/Updates
Table 84. PRA Health Sciences Competitive Strengths & Weaknesses
Table 85. PCI Pharma Services Basic Information, Area Served and Competitors
Table 86. PCI Pharma Services Major Business
Table 87. PCI Pharma Services Clinical Trial Material Product and Services
Table 88. PCI Pharma Services Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. PCI Pharma Services Recent Developments/Updates
Table 90. PCI Pharma Services Competitive Strengths & Weaknesses
Table 91. Capsugel Basic Information, Area Served and Competitors
Table 92. Capsugel Major Business
Table 93. Capsugel Clinical Trial Material Product and Services
Table 94. Capsugel Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Capsugel Recent Developments/Updates
Table 96. Capsugel Competitive Strengths & Weaknesses
Table 97. OCT Group Basic Information, Area Served and Competitors
Table 98. OCT Group Major Business
Table 99. OCT Group Clinical Trial Material Product and Services
Table 100. OCT Group Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. OCT Group Recent Developments/Updates
Table 102. OCT Group Competitive Strengths & Weaknesses
Table 103. Acnos Pharma Basic Information, Area Served and Competitors
Table 104. Acnos Pharma Major Business
Table 105. Acnos Pharma Clinical Trial Material Product and Services
Table 106. Acnos Pharma Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Acnos Pharma Recent Developments/Updates
Table 108. Acnos Pharma Competitive Strengths & Weaknesses
Table 109. KLIFO Basic Information, Area Served and Competitors
Table 110. KLIFO Major Business
Table 111. KLIFO Clinical Trial Material Product and Services
Table 112. KLIFO Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. KLIFO Recent Developments/Updates
Table 114. KLIFO Competitive Strengths & Weaknesses
Table 115. Ancillare, LP Basic Information, Area Served and Competitors
Table 116. Ancillare, LP Major Business
Table 117. Ancillare, LP Clinical Trial Material Product and Services
Table 118. Ancillare, LP Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Ancillare, LP Recent Developments/Updates
Table 120. Ancillare, LP Competitive Strengths & Weaknesses
Table 121. ADAllen Pharma Basic Information, Area Served and Competitors
Table 122. ADAllen Pharma Major Business
Table 123. ADAllen Pharma Clinical Trial Material Product and Services
Table 124. ADAllen Pharma Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. ADAllen Pharma Recent Developments/Updates
Table 126. ADAllen Pharma Competitive Strengths & Weaknesses
Table 127. Recipharm Basic Information, Area Served and Competitors
Table 128. Recipharm Major Business
Table 129. Recipharm Clinical Trial Material Product and Services
Table 130. Recipharm Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Recipharm Recent Developments/Updates
Table 132. Movianto Basic Information, Area Served and Competitors
Table 133. Movianto Major Business
Table 134. Movianto Clinical Trial Material Product and Services
Table 135. Movianto Clinical Trial Material Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 136. Clinical Trial Material Raw Material
Table 137. Key Manufacturers of Clinical Trial Material Raw Materials
Table 138. Clinical Trial Material Typical Distributors
Table 139. Clinical Trial Material Typical Customers
LIST OF FIGURES
Figure 1. Clinical Trial Material Picture
Figure 2. World Clinical Trial Material Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Clinical Trial Material Total Market Size (2017-2028) & (USD Million)
Figure 4. World Clinical Trial Material Market Size Market Share by Region (2017-2028)
Figure 5. United States Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 6. China Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 7. Europe Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 8. Japan Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 11. India Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 12. Clinical Trial Material Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Clinical Trial Material by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Clinical Trial Material Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Clinical Trial Material Markets in 2021
Figure 17. United States VS China: Clinical Trial Material Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Clinical Trial Material Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Clinical Trial Material Market Size Market Share by Type in 2021
Figure 20. Small-molecules
Figure 21. Biologic Drugs
Figure 22. Medical Devices
Figure 23. World Clinical Trial Material Market Size Market Share by Type (2017-2028)
Figure 24. World Clinical Trial Material Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Clinical Trial Material Market Size Market Share by Application in 2021
Figure 26. Oncology
Figure 27. CNS
Figure 28. Cardiovascular Diseases
Figure 29. Digestive Disorders
Figure 30. Immunology
Figure 31. Blood Disorders
Figure 32. Other
Figure 33. World Clinical Trial Material Market Size Market Share by Application (2017-2028)
Figure 34. Manufacturing Cost Structure Analysis of Clinical Trial Material in 2021
Figure 35. Manufacturing Process Analysis of Clinical Trial Material
Figure 36. Clinical Trial Material Industrial Chain
Figure 37. Distribution Channel Breakdown for Clinical Trial Material Shipments (%): 2017-2028
Figure 38. Direct Channel Pros & Cons
Figure 39. Indirect Channel Pros & Cons
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Clinical Trial Material Picture
Figure 2. World Clinical Trial Material Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Clinical Trial Material Total Market Size (2017-2028) & (USD Million)
Figure 4. World Clinical Trial Material Market Size Market Share by Region (2017-2028)
Figure 5. United States Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 6. China Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 7. Europe Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 8. Japan Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 11. India Clinical Trial Material Market Size (2017-2028) & (USD Million)
Figure 12. Clinical Trial Material Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Clinical Trial Material by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Clinical Trial Material Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Clinical Trial Material Markets in 2021
Figure 17. United States VS China: Clinical Trial Material Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Clinical Trial Material Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Clinical Trial Material Market Size Market Share by Type in 2021
Figure 20. Small-molecules
Figure 21. Biologic Drugs
Figure 22. Medical Devices
Figure 23. World Clinical Trial Material Market Size Market Share by Type (2017-2028)
Figure 24. World Clinical Trial Material Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Clinical Trial Material Market Size Market Share by Application in 2021
Figure 26. Oncology
Figure 27. CNS
Figure 28. Cardiovascular Diseases
Figure 29. Digestive Disorders
Figure 30. Immunology
Figure 31. Blood Disorders
Figure 32. Other
Figure 33. World Clinical Trial Material Market Size Market Share by Application (2017-2028)
Figure 34. Manufacturing Cost Structure Analysis of Clinical Trial Material in 2021
Figure 35. Manufacturing Process Analysis of Clinical Trial Material
Figure 36. Clinical Trial Material Industrial Chain
Figure 37. Distribution Channel Breakdown for Clinical Trial Material Shipments (%): 2017-2028
Figure 38. Direct Channel Pros & Cons
Figure 39. Indirect Channel Pros & Cons
Figure 40. Methodology
Figure 41. Research Process and Data Source
